Search Results - "Martínez del Prado, María Purificación"

Predictors of readmission and reoperation in patients with colorectal cancer by Quintana, José M., Anton-Ladislao, Ane, Lázaro, Santiago, Gonzalez, Nerea, Bare, Marisa, de Larrea, Nerea Fernandez, Redondo, Maximino, Briones, Eduardo, Escobar, Antonio, Sarasqueta, Cristina, Garcia-Gutierrez, Susana

“…Purpose To assess the impact of readmission and reoperation on colon or rectal cancer patients in clinical and patient-reported outcome measures (PROMs) and to…”
Get full text

Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM) by Sánchez Cánovas, Manuel, López Robles, Javier, Adoamnei, Evdochia, Cacho Lavin, Diego, Diaz Pedroche, Carmen, Coma Salvans, Eva, Quintanar Verduguez, Teresa, García Verdejo, Francisco José, Cejuela Solís, Mónica, García Adrián, Silvia, Obispo Portero, Berta, Garrido Fernández, Alberto, Salvador Coloma, Carmen, Martínez del Prado, María Purificación, Mendiola, Jaime, Muñoz Martín, Andres J.

“…•Thrombotic risk from CDK 4/6 inhibitors is higher in practice than in RCT data.•This risk appears to be significant if the drug used is abemaciclib.•VTE/AT…”
Get full text

Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer by Mar, Javier, Anton-Ladislao, Ane, Ibarrondo, Oliver, Arrospide, Arantzazu, Lázaro, Santiago, Gonzalez, Nerea, Bare, Marisa, Callejo, Daniel, Redondo, Maximino, Quintana, José M.

“…Background Few economic evaluations have assessed laparoscopy for colon cancer. This study aimed to compare the cost-effectiveness of laparoscopic and open…”
Get full text

Abstract RF01-03: PARSIFAL-LONG: Extended follow-up of hormone receptor-positive/HER2-negative advanced breast cancer patients treated with fulvestrant and palbociclib vs. letrozole and palbociclib in the PARSIFAL study by Llombart-Cussac, Antonio, Pérez-García, José Manuel, Ezquerra, Meritxell Bellet, Dalenc, Florence, Gil-Gil, Miguel, Ruíz - Borrego, Manuel, Gavilá, Joaquín, Schmid, Peter, Zamora, Pilar, Wheatley, Duncan, Dueñas, Eduardo Martínez-de, Amillano, Kepa, Antón, Antonio, Cottu, Paul, Viñas, Gemma, Petit, Thierry, Tesarová, Petra, Cueva, Juan, Colleoni, Marco, Prado, Maria Purificación Martínez del, Andrés, Raquel, Cabo, Marta Díaz, Victorino, Susana, Sampayo-Cordero, Miguel, Cortés, Javier

“…Background: The Phase 2 PARSIFAL study assessed whether fulvestrant (FUL) or letrozole (LET) was the optimal endocrine partner for the cyclin-dependent kinase…”
Get full text

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real‐World Data from the Spanish Tumor Registry (R‐GETNE) by Nuñez‐Valdovinos, Barbara, Carmona‐Bayonas, Alberto, Jimenez‐Fonseca, Paula, Capdevila, Jaume, Castaño‐Pascual, Ángel, Benavent, Marta, Pi Barrio, Jose Javier, Teule, Alex, Alonso, Vicente, Custodio, Ana, Marazuela, Monica, Segura, Ángel, Beguiristain, Adolfo, Llanos, Marta, Martinez del Prado, Maria Purificacion, Diaz‐Perez, Jose Angel, Castellano, Daniel, Sevilla, Isabel, Lopez, Carlos, Alonso, Teresa, Garcia‐Carbonero, Rocio

“…Background Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are a complex family of tumors of widely variable clinical behavior. The World Health…”
Get full text

Leveraging Large Language Models for Precision Monitoring of Chemotherapy-Induced Toxicities: A Pilot Study with Expert Comparisons and Future Directions by Ruiz Sarrias, Oskitz, Martínez Del Prado, María Purificación, Sala Gonzalez, María Ángeles, Azcuna Sagarduy, Josune, Casado Cuesta, Pablo, Figaredo Berjano, Covadonga, Galve-Calvo, Elena, López de San Vicente Hernández, Borja, López-Santillán, María, Nuño Escolástico, Maitane, Sánchez Togneri, Laura, Sande Sardina, Laura, Pérez Hoyos, María Teresa, Abad Villar, María Teresa, Zabalza Zudaire, Maialen, Sayar Beristain, Onintza

“…Large Language Models (LLMs), such as the GPT model family from OpenAI, have demonstrated transformative potential across various fields, especially in…”
Get full text

Abstract P3-14-05: Oncotype DX assay’s real world data in early stage breast cancer patients. Outcomes of a cohort treated in the Basurto University Hospital, Spain by del Prado, Maria Purificacion Martínez, Vicente, Borja López de San, Arteaga, Juan Fernando Arango, Folgueira, Jairo Legaspi, Cuesta, Ane Zumárraga, Diaz, Fernando Pikabea, Vidal, Patricia Novas, Santillán, María López, Sardina, Laura Sande, Escolástico, Maitane Nuño, Villar, María Teresa Abad, Gonzalez, Maria Ángeles Sala, Berjano, Covadonga Figaredo, Hoyos, María Teresa Pérez, Calvo, Elena Galve

“…Introduction: Oncotype DX (ODX) Recurrence Score (RS) is a gene-expression assay that provides prognostic and predictive information in hormonal-receptor…”
Get full text